Do you want to read an article? Please log in or register.
Risk factors for type 1 and type 2 myocardial infarction
Myocardial Infarction
Related content
Heart FailureMyocardial Infarction
Contrasting Associations of Body Mass Index and Hemoglobin A1c on the Excess Risk of Acute Myocardial Infarction and Heart Failure in Type 2 Diabetes Mellitus
J Am Heart Assoc.
Edqvist J, Rawshani A, Adiels M, Björck L, Lind M, Svensson AM, Gudbjörnsdottir S, Sattar N, Rosengren A
doi: 10.1161/JAHA.119.013871.
Myocardial Infarction
Modifiable Risk Factors in Young Adults With First Myocardial Infarction
J Am Coll Cardiol.
Yandrapalli S, Nabors C, Goyal A, Aronow WS, Frishman WH
doi: 10.1016/j.jacc.2018.10.084.
Myocardial Infarction
Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction
J Am Coll Cardiol
McCarthy CP, Kolte D, Kennedy KF, Vaduganathan M, Wasfy JH, Januzzi JL Jr
doi: 10.1016/j.jacc.2020.12.034
Cardiovascular Risk and DiseasesMyocardial Infarction
Glucagon-like peptide 1 levels predict cardiovascular risk in patients with acute myocardial infarction
Eur Heart J.
Kahles F, Rückbeil MV, Mertens RW, Foldenauer AC, Arrivas MC, Moellmann J, Lebherz C, Biener M, Giannitsis E, Katus HA, Marx N, Lehrke M
doi: 10.1093/eurheartj/ehz728.
Myocardial Infarction
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction
Circulation.
Horiuchi Y, Wettersten N, Patel MP, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke GM, Daniels LB, Hollander JE, Apple FS, Cannon CM, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Headden G, Limkakeng AT, Anand I, Wu AHB, Ebmeyer S, Jaffe AS, Peacock WF, Maisel AS
doi: 10.1161/CIRCULATIONAHA.
Myocardial Infarction
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction
Eur Heart J.
Thrane PG, Kristensen SD, Olesen KKW, Mortensen LS, Bøtker HE, Thuesen L, Hansen HS, Abildgaard U, Engstrøm T, Andersen HR, Maeng M
doi: 10.1093/eurheartj/ehz595.
Cardiovascular Risk and DiseasesHeart FailureMyocardial Infarction
Silent Myocardial Infarction and Long-Term Risk of Heart Failure: The ARIC Study
J Am Coll Cardiol.
Qureshi WT, Zhang ZM, Chang PP, Rosamond WD, Kitzman DW, Wagenknecht LE, Soliman EZ
doi: 10.1016/j.jacc.2017.10.071.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
N Engl J Med.
Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK1, Sattar N, Rosengren A, Gudbjörnsdottir S
doi: 10.1056/NEJMoa1608664.
COMMENTED
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesHeart FailureMyocardial InfarctionThrombosis and Stroke
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
★ 2
Recommended and commented by
Prof. Dr emer. Josef Flammer, Faculty Member
BMJ
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM
doi: 10.1136/bmj.m4573